---
title: "Unique Friend | Hengfang Health’s Xue Yuanxin: Customers Buy Outcomes, Not AI Concepts"
author: "Unique Research"
sourcePublication: "Unique Research (FFCAP English library)"
originalPublishedAt: "2024-01-15T16:30:00+08:00"
canonical: "https://ffcap.cn/en/research/20240115a05n1t00"
source: "https://ffcap.cn/en/research/20240115a05n1t00"
language: "en"
cnSourceUrl: "https://view.inews.qq.com/a/20240115A05N1T00"
---

# Unique Friend | Hengfang Health’s Xue Yuanxin: Customers Buy Outcomes, Not AI Concepts

_Unique Research · Insight / Unique Friend Q&A · January 15, 2024 · Guest: Xue Yuanxin, PhD, Founder, Hengfang Health (横方健康)_

Inventory type remains **insight** (Unique Friend series — not partner welcome).

## Guest

**Xue Yuanxin** — PhD; ex-Huawei; B+ O2O founder; Hengfang Health founder. Covered by Xinhua, CCTV, People’s Daily and local TV; multiple entrepreneurship awards.

**Hengfang Health** — leading intelligent doctor assistant; VC-backed at founding; Huawei Pangu LLM healthcare strategic partner. Welcomed by experts at PUMCH, Sun Yat-sen, Ruijin, Renji and peers. **1M+ active patients**, **1,000+ partner doctors**, 25 provinces; pharma partnerships; commercial profitability.

## Q&A

**1\. Product and core scenarios?**  
Public healthcare’s impossible triangle (cost–efficiency–service) is global. LLM breakthroughs open a path. Hengfang smart doctor assistant on Pangu addresses “5 hours wait, 5 minutes care” — delivering **5,000–50,000 minutes** of online assist per outpatient — welcomed by patients, doctors, government, pharma; commercially live.

**2\. R&D / GTM; biggest 2023 challenge and win?**  
Product 3.0; early commercialization (1M+ patients, 1,000+ doctors, 25 provinces, pharma deals, profitability). Challenge/win: Huawei Pangu support for new iteration + successful commercialization.

**3\. China landing challenges?**  
Shell wrappers lack longevity — need deep head-firm partnerships; few true AI-native apps (mostly local efficiency patches); missing commercial closed loops — still “cost-cut” rhetoric.

**4\. Key product / GTM factors?**  
Don’t do AI for AI’s sake — customers buy benefit, not concepts. Don’t overrate AI: if AI only lifts one link in a multi-link business, overall advantage may be weak — skip hype; create real customer value.

**5\. Competing with giants?**  
Deep scene models; bind customers early and commercialize early.

**6\. Human–machine collaboration?**  
Distinguish tool-attribute (local efficiency) vs new-business-attribute (native apps) — different value.

_1 CN image; attach on ingest. Signup CTA in CN omitted._

— END —

---

Editorial English edition published on UniqueCapital: https://ffcap.cn/en/research/20240115a05n1t00
On-site reading page: https://ffcap.cn/en/research/20240115a05n1t00